InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,836.05
(
-2.51%
)

Replies to post #247052 on Biotech Values

Replies to #247052 on Biotech Values

DewDiligence

05/19/23 12:49 PM

#247073 RE: DewDiligence #247052

Addendum—Rinvoq is the first oral med approved for Crohn's disease.